Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

This study has been terminated.
(Due to a pre-planned Interim Analysis 20060540 study was stopped for futility with no safety concerns. 20080261 study has also been stopped as a result of this)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01318642
First received: March 17, 2011
Last updated: March 29, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)